Glioma News and Research

RSS
Glioma is a cancer of the brain that begins in glial cells (cells that surround and support nerve cells).
Scientists report first successful step toward vaccine that targets mutation in brain cancer

Scientists report first successful step toward vaccine that targets mutation in brain cancer

EnGeneIC plans for Phase 2a trial of EGFR-targeted doxorubicin-packaged EDV nanocells for GBM

EnGeneIC plans for Phase 2a trial of EGFR-targeted doxorubicin-packaged EDV nanocells for GBM

Researchers shed new light on how gliomas cells migrate in brain and cause devastating tumors

Researchers shed new light on how gliomas cells migrate in brain and cause devastating tumors

New class of tumor-targeting agents can seek out dozens of solid tumors

New class of tumor-targeting agents can seek out dozens of solid tumors

Northwest Biotherapeutics initiates Phase III trial of DCVax-L in Germany

Northwest Biotherapeutics initiates Phase III trial of DCVax-L in Germany

Gene variants that lead to longer telomeres boost brain cancer risk

Gene variants that lead to longer telomeres boost brain cancer risk

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Collaborative research effort produces new genetic insights into brainstem glioma

Collaborative research effort produces new genetic insights into brainstem glioma

ASCO: DelMar presents interim data from VAL-083 clinical trial in refractory GBM

ASCO: DelMar presents interim data from VAL-083 clinical trial in refractory GBM

Angiochem presents data on ANG1005 paclitaxel-peptide drug conjugate at 50th ASCO annual meeting

Angiochem presents data on ANG1005 paclitaxel-peptide drug conjugate at 50th ASCO annual meeting

FDA grants Angiochem’s ANG1005 fast track and orphan drug designation for treatment of glioblastoma multiforme

FDA grants Angiochem’s ANG1005 fast track and orphan drug designation for treatment of glioblastoma multiforme

Angiochem commences ANG1005 Phase 2 clinical study in HER2+ breast cancer patients with brain metastases

Angiochem commences ANG1005 Phase 2 clinical study in HER2+ breast cancer patients with brain metastases

TAG-1 induces apoptosis-related gene expression without triggering apoptosis in glioma cells

TAG-1 induces apoptosis-related gene expression without triggering apoptosis in glioma cells

Herpes simplex viral therapy in conjunction with radiation proves effective in treating malignant gliomas

Herpes simplex viral therapy in conjunction with radiation proves effective in treating malignant gliomas

Researchers identify potential treatment targets for incurable form of pediatric brain cancer

Researchers identify potential treatment targets for incurable form of pediatric brain cancer

Genome Project offers new leads to improve outcomes for children with high-grade glioma brain tumors

Genome Project offers new leads to improve outcomes for children with high-grade glioma brain tumors

Researchers use ultrasound to destroy cancerous tissue in brain

Researchers use ultrasound to destroy cancerous tissue in brain

Study establishes innovative approaches to improve vision of young children with brain tumor

Study establishes innovative approaches to improve vision of young children with brain tumor

Chemotherapy following radiation therapy improves survival for adults with brain tumor

Chemotherapy following radiation therapy improves survival for adults with brain tumor

Children who received radiation as part of treatment may have lower long-term survival rates, says study

Children who received radiation as part of treatment may have lower long-term survival rates, says study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.